Vimarsana
Biggest News Aggregation in the World

Page 30 - Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Today - Breaking & Trending Today

Bristol Myers Squibb (BMY) earnings Q1 2024 - Vimarsana News

Bristol Myers Squibb (BMY) earnings Q1 2024

Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.

Source: cnbc.com
Merck (MRK) earnings Q1 2024 - Vimarsana News

Merck (MRK) earnings Q1 2024

The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.

Source: cnbc.com
| Agri-Pulse Communications, Inc. - Vimarsana News

| Agri-Pulse Communications, Inc.

Agri-Pulse is a trusted source in Washington, D.C., with the largest editorial team focused on food, fuel, fiber and farm policy coverage. Agri-Pulse presents a balanced perspective on a wide variety of issues.

Wegovy: 3.6 million Medicare patients could get heart health coverage - Vimarsana News

Wegovy: 3.6 million Medicare patients could get heart health coverage

For the first time, some Medicare beneficiaries will be able to access Novo Nordisk's Wegovy without having to shoulder the total monthly price tag.

Source: cnbc.com
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump - Vimarsana News

Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump

Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19 products and a number of its cancer drugs.

Source: cnbc.com